Multicentric Castleman Disease: Where Are We Now?

Overview

Journal Semin Diagn Pathol

Date 2016 Jun 15

PMID 27296355

Citations 56

Authors

Hao-Wei Wang

Stefania Pittaluga

Elaine S Jaffe

Affiliations

Soon will be listed here.

Abstract

Multicentric Castleman disease (MCD) encompasses a spectrum of conditions that give rise to overlapping clinicopathological manifestations. The fundamental pathogenetic mechanism involves dysregulated cytokine activity that causes systemic inflammatory symptoms as well as lymphadenopathy. The histological changes in lymph nodes resemble in part the findings originally described in the unicentric forms Castleman disease, both hyaline vascular and plasma cell variants. In MCD caused by Kaposi sarcoma-associated herpesvirus/human herpesvirus-8 (KSHV/HHV8), the cytokine over activity is caused by viral products, which can also lead to atypical lymphoproliferations and potential progression to lymphoma. In cases negative for KSHV/HHV8, so-called idiopathic MCD, the hypercytokinemia can result from various mechanisms, which ultimately lead to different constellations of clinical presentations and varied pathology in lymphoid tissues. In this article, we review the evolving concepts and definitions of the various conditions under the eponym of Castleman disease, and summarize current knowledge regarding the histopathology and pathogenesis of lesions within the MCD spectrum.

Citing Articles

Castleman disease misdiagnosed as immunoglobulin G4-related disease: a case report.

Li N, Xu L, Liu X, Wu P, Liu J, Zeng J Front Immunol. 2025; 16:1532627.

PMID: 39935479 PMC: 11810934. DOI: 10.3389/fimmu.2025.1532627.

Multicentric Castleman Disease: A Case Report of an Arab Female.

Mansour M, Zayat A Cureus. 2024; 16(10):e71112.

PMID: 39525135 PMC: 11543861. DOI: 10.7759/cureus.71112.

[Rheumatoid arthritis with Castleman-like histopathology in lymph nodes: A case report].

Liu D, Chen J, Gao M, Yu J Beijing Da Xue Xue Bao Yi Xue Ban. 2024; 56(5):928-931.

PMID: 39397477 PMC: 11480558.

Spatial and Single Cell Mapping of Castleman Disease Reveals Key Stromal Cell Types and Cytokine Pathways.

Smith D, Eichinger A, Rech A, Wang J, Esteva E, Seyedian A bioRxiv. 2024; .

PMID: 39314418 PMC: 11419132. DOI: 10.1101/2024.09.09.609717.

Complex Presentation of Multicentric Castleman Disease with Coexisting HIV, HHV-8, and Other Opportunistic Infections.

Tlaiss Y, Farhat H, Hasan F, Yazbek R, Shakaroun N, Bitar N Case Rep Hematol. 2024; 2024:8817064.

PMID: 39104429 PMC: 11300082. DOI: 10.1155/2024/8817064.

References

Bhutani M, Polizzotto M, Uldrick T, Yarchoan R . Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment. Semin Oncol. 2015; 42(2):223-46. PMC: 6309362. DOI: 10.1053/j.seminoncol.2014.12.027. View

Ishido S, Wang C, Lee B, COHEN G, Jung J . Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol. 2000; 74(11):5300-9. PMC: 110885. DOI: 10.1128/jvi.74.11.5300-5309.2000. View

Chang H, Dittmer D, Shin Y, Chul S, Hong Y, Jung J . Role of Notch signal transduction in Kaposi's sarcoma-associated herpesvirus gene expression. J Virol. 2005; 79(22):14371-82. PMC: 1280196. DOI: 10.1128/JVI.79.22.14371-14382.2005. View

Ballestas M, Chatis P, Kaye K . Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science. 1999; 284(5414):641-4. DOI: 10.1126/science.284.5414.641. View

Derudder E, Cadera E, Vahl J, Wang J, Fox C, Zha S . Development of immunoglobulin lambda-chain-positive B cells, but not editing of immunoglobulin kappa-chain, depends on NF-kappaB signals. Nat Immunol. 2009; 10(6):647-54. PMC: 2742984. DOI: 10.1038/ni.1732. View

Boulanger M, Chow D, Brevnova E, Martick M, Sandford G, Nicholas J . Molecular mechanisms for viral mimicry of a human cytokine: activation of gp130 by HHV-8 interleukin-6. J Mol Biol. 2003; 335(2):641-54. DOI: 10.1016/j.jmb.2003.10.070. View

Staskus K, Sun R, Miller G, Racz P, Jaslowski A, Metroka C . Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol. 1999; 73(5):4181-7. PMC: 104197. DOI: 10.1128/JVI.73.5.4181-4187.1999. View

Salata C, Curtarello M, Calistri A, Sartori E, Sette P, de Bernard M . vOX2 glycoprotein of human herpesvirus 8 modulates human primary macrophages activity. J Cell Physiol. 2009; 219(3):698-706. DOI: 10.1002/jcp.21722. View

Gunther T, Grundhoff A . The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog. 2010; 6(6):e1000935. PMC: 2880564. DOI: 10.1371/journal.ppat.1000935. View

10.

Weber K, Grone H, Rocken M, Klier C, Gu S, Wank R . Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II. Eur J Immunol. 2001; 31(8):2458-66. DOI: 10.1002/1521-4141(200108)31:8<2458::aid-immu2458>3.0.co;2-l. View

11.

Nakamura H, Nakaseko C, Ishii A, Kogure K, Kawano E, Hashimoto S . [Chromosomal abnormalities in Castleman's disease with high levels of serum interleukin-6]. Rinsho Ketsueki. 1993; 34(2):212-7. View

12.

Montes-Moreno S, Montalban C, Piris M . Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge. Leuk Lymphoma. 2011; 53(2):185-94. DOI: 10.3109/10428194.2011.608447. View

13.

Coscoy L, Ganem D . Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci U S A. 2000; 97(14):8051-6. PMC: 16668. DOI: 10.1073/pnas.140129797. View

14.

Bais C, Van Geelen A, Eroles P, Mutlu A, Chiozzini C, Dias S . Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. Cancer Cell. 2003; 3(2):131-43. DOI: 10.1016/s1535-6108(03)00024-2. View

15.

Frizzera G . Castleman's disease and related disorders. Semin Diagn Pathol. 1988; 5(4):346-64. View

16.

An J, Sun Y, Sun R, Rettig M . Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways. Oncogene. 2003; 22(22):3371-85. DOI: 10.1038/sj.onc.1206407. View

17.

Fajgenbaum D, van Rhee F, Nabel C . HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood. 2014; 123(19):2924-33. DOI: 10.1182/blood-2013-12-545087. View

18.

Hall P, Donaghy M, Cotter F, Stansfeld A, Levison D . An immunohistological and genotypic study of the plasma cell form of Castleman's disease. Histopathology. 1989; 14(4):333-46; discussion 429-32. DOI: 10.1111/j.1365-2559.1989.tb02162.x. View

19.

Li C, Ye H, Liu H, Du M, Chuang S . Fatal HHV-8-associated hemophagocytic syndrome in an HIV-negative immunocompetent patient with plasmablastic variant of multicentric Castleman disease (plasmablastic microlymphoma). Am J Surg Pathol. 2005; 30(1):123-7. DOI: 10.1097/01.pas.0000172293.59785.b4. View

20.

Cesarman E . Gammaherpesviruses and lymphoproliferative disorders. Annu Rev Pathol. 2013; 9:349-72. DOI: 10.1146/annurev-pathol-012513-104656. View